Pull to refresh
Logo
American Cancer Society

American Cancer Society

Nonprofit health organization

Appears in 4 stories · Last updated Oct 19, 2026

Stories

US five-year cancer survival reaches record 71 percent

New Capabilities

Publishes the authoritative annual Cancer Statistics report

A cancer diagnosis in the mid-1970s was close to a coin flip: only 49% of patients lived five years. Today, 71% do — the highest rate on record. The American Association for Cancer Research's 2026 progress report credits better screening, improved surgery and radiation, and a wave of drugs that harness the immune system or target specific tumor mutations.

Updated Oct 19

Abbott launches SimpleScreen CRC blood test for colorectal cancer screening

New Capabilities

As of September 2026: Sets screening guidelines that shape which tests doctors recommend

Abbott began selling SimpleScreen CRC on September 30, giving average-risk Americans 45 and older a second FDA-approved blood test for colorectal cancer screening. The test reads cell-free DNA from a simple blood draw for signals associated with cancer. Abbott is betting it reaches people who never complete a colonoscopy or stool test.

Updated Sep 30

Colorectal cancer takes younger lives as public figures sound the alarm

New Capabilities

As of May 2026: Sets screening guidelines

Colorectal cancer now kills more Americans under 50 than any other cancer. James Van Der Beek, who played Dawson Leery in the late-1990s teen drama Dawson's Creek, died February 11 at age 48 after a 30-month battle with colorectal cancer. He became the latest public figure to put a face on an epidemic that medical guidelines have only recently begun to address.

Updated May 27

The 34-year retreat of cancer death rates

New Capabilities

As of May 2026: Publishes annual Cancer Facts & Figures report

Cancer death rates in the United States peaked in 1991 at 215 deaths per 100,000 people and have since fallen 34%, averting an estimated 4.5 million deaths. The decline accelerated from about 1% annually in the 1990s to 2% annually by 2015-2020, driven by plummeting smoking rates, earlier detection through screening, and advances in targeted therapies and immunotherapy.

Updated May 22